Skip to main content
OpenTrials
Completed

NCT Number: NCT05777096

Prevalence of Non-traumatic Musculoskeletal Disorders in the French Paragliding Pilots Population

The main objective is to determine the prevalence of non-traumatic pathologies in the paragliding population using the Nordic type questionnaire.

The paragliding pilots population frequently evoque pathologies, discomfort, or pain in the course of their practice. Said pain and discomfort, though unerelated any form of accident, seem to have an impact on the pilots' flying and their participation in daily life.

However, no epidemiological data are available in the literature. Investigators hypothesize the existence of non-traumatic disorders and it seems interesting to quantify the extent of the phenomenon. The results of this study might encourage the proposition of preventive measures in order to minimize a potential risk factor for paragliding accidents, and participation restrictions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prevalence Cumulative Trauma Disorders Musculoskeletal Diseases Musculoskeletal Disorders Sprains and Strains Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Grenoble Alpes University - Faculty of Medecine - Departement of Physiotherapy

Saint-Martin-d'Hères, 38400, France

About this study

In this cross-sectional descriptive epidemiological survey, investigators wish to quantify epidemiological parameters such as the prevalence of pathologies and their consequences in the activities of daily life.

For this purpose, an email containing the link to answer the online questionnaire will be sent to all the licensees.

The link of the questionnaire will be sent directly to all clubs in each league.

The main objective is to calculate the prevalence with descriptive statistics. The primary outcome is the prevalence of non-traumatic pathology in paragliding pilots that had registered to the French Paragliding federation (FFVL) in 2022.

The prevalence will be infered from the IRSST Standardised Nordic Questionnaire with the following formula : Prevalence = (FS4+FS6=yes and FS2=no ) divided by the total number of respondents.

FS4 item "Yes" = pain in the last 12 months FS6 item "Yes" = activity limitations) FS2 item "No" = Non-traumatic disorders

This corresponds to having felt pain in the body region indicated, at least once during the last 12 months, as well as a restriction of participation following this pain, but without having suffered trauma in the area.

For the secondary outcomes will aim at exploring several hypotheses related to personal and environmental factors that could be correlated to the incidence of the nontraumatic disorders. They will be calculated with bivariate descriptive statistics using the Pvalue.io software.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • over 18 years old
  • Registered with the FFVL for the year 2022 and/or 2023
  • Paragliding in the year 2022 and/or 2023

Exclusion criteria

  • Adults not able to express their consent

Treatment and study plan

Standardised Nordic questionnaires

Diagnostic Test

participants will complete the SNQ online. Estimated time of participation per person: 15 minutes to fill in the questionnaires

Primary outcomes

  1. Prevalence of non-traumatic pathologies in the paragliding pilot population

    Time frame: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

    The prevalence will be calculated using the IRSST's Standardised Nordic Questionnaire.

    Prevalence = (FS4+FS6=yes and FS2=no ) on total number of respondents. This prevalence will be calculated on the Population Health, with the FS4 and FS6 items. And to be more specific about atraumatic pathologies, it is necessary to have answered "no" to the FS2 item. This corresponds to having felt pain in the body region indicated, at least once during the last 12 months, as well as a restriction of participation following this pain, but without having undergone trauma in the area concerned.

Secondary outcomes

  1. Correlations between prevalence, a body area, restriction of participation in paragliding and individual characteristics of participants

    Time frame: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

    Correlation analysis (univariate and bivariate) between responses to different questions to test for a potential association between variables

  2. Paragliders' beliefs about the origin of their pain.

    Time frame: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

    Number of respondents with musculoskeletal disorder (FS9=yes)/total number of positive cases ((FS4+FS6=yes and FS2=no)

  3. Prevalence of injuries sustained during a paragliding accident

    Time frame: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

    Number of respondents with musculoskeletal disorder due to accident/total number of pain positive cases and participation restriction ((FS4+FS6=yes and FS2.3=yes)

Sponsors and collaborators

Lead sponsor

University Hospital, Grenoble

Other

Registry information

Acronym: EPPPAF

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Mar 21, 2023
Registry last updated
Mar 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.